Archives
AACR: Adjuvant Atezolizumab + Bevacizumab Beneficial in Liver Cancer
Increased recurrence-free survival seen for patients with high-risk HCC following resection or ablation
Black Patients More Likely to Have Heart Damage Following Chemo
Compared with White patients, Black patients have 71 percent higher odds of cardiotoxicity
AACR: mRNA-4157 Plus Pembrolizumab Beneficial in Melanoma
Combination of mRNA vaccine and pembrolizumab significantly prolongs recurrence-free survival versus pembrolizumab alone
AACR: Awareness That HPV Causes Cancer Is Ebbing Among Americans
Furthermore, U.S. vaccination rates for preteens and teens are well below recommended goals
HIV Infection Tied to Higher Risk for Depression
Family-related factors unlikely to entirely explain this risk, authors say
Not Enough Antibiotics in Drug Development Pipeline, WHO Says
Few in development are innovative enough to target critical, drug-resistant pathogens
AAD: Promising Results Seen for Bimekizumab in Hidradenitis Suppurativa
Significantly higher proportion of hidradenitis suppurativa patients treated with bimekizumab achieved primary end point of HiSCR50
AAD: Long-Term Improvement Seen With Ruxolitinib in Vitiligo
Improvement in facial/total Vitiligo Area Scoring Index seen with continued treatment from weeks 52 to 104
AAD: Risk for Skin Cancer Higher for Adults With Atopic Dermatitis
Significantly increased risk seen for adults with moderate-to-severe versus mild atopic dermatitis
Hydrocortisone Linked to Lower Risk for Death in Severe Pneumonia
Findings seen among adults who had been admitted to the ICU for severe community-acquired pneumonia
